HIF1A and neoplasm: There is clinical evidence of an effect of NTG on expression of HIF-1α, with immunostaining of tumour samples showing decreased levels of expression of HIF-1α and VEGF in NSCLC patients treated with NTG patches compared to non-treated controls [28].